These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 32493822)

  • 1. Filoviruses Use the HOPS Complex and UVRAG To Traffic to Niemann-Pick C1 Compartments during Viral Entry.
    Bo Y; Qiu S; Mulloy RP; Côté M
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32493822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1.
    Carette JE; Raaben M; Wong AC; Herbert AS; Obernosterer G; Mulherkar N; Kuehne AI; Kranzusch PJ; Griffin AM; Ruthel G; Dal Cin P; Dye JM; Whelan SP; Chandran K; Brummelkamp TR
    Nature; 2011 Aug; 477(7364):340-3. PubMed ID: 21866103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Intracellular Visualization of Ebola Virus-Receptor Interaction by
    Mittler E; Alkutkar T; Jangra RK; Chandran K
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway.
    Spence JS; Krause TB; Mittler E; Jangra RK; Chandran K
    mBio; 2016 Feb; 7(1):e01857-15. PubMed ID: 26861015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments.
    Stewart CM; Phan A; Bo Y; LeBlond ND; Smith TKT; Laroche G; Giguère PM; Fullerton MD; Pelchat M; Kobasa D; Côté M
    PLoS Pathog; 2021 Jan; 17(1):e1009275. PubMed ID: 33513206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two Distinct Lysosomal Targeting Strategies Afford Trojan Horse Antibodies With Pan-Filovirus Activity.
    Wirchnianski AS; Wec AZ; Nyakatura EK; Herbert AS; Slough MM; Kuehne AI; Mittler E; Jangra RK; Teruya J; Dye JM; Lai JR; Chandran K
    Front Immunol; 2021; 12():729851. PubMed ID: 34721393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential pharmacological strategies targeting the Niemann-Pick C1 receptor and Ebola virus glycoprotein interaction.
    Morales-Tenorio M; Ginex T; Cuesta-Geijo MÁ; Campillo NE; Muñoz-Fontela C; Alonso C; Delgado R; Gil C
    Eur J Med Chem; 2021 Nov; 223():113654. PubMed ID: 34175537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step.
    Mingo RM; Simmons JA; Shoemaker CJ; Nelson EA; Schornberg KL; D'Souza RS; Casanova JE; White JM
    J Virol; 2015 Mar; 89(5):2931-43. PubMed ID: 25552710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Virion-Based Assay for Glycoprotein Thermostability Reveals Key Determinants of Filovirus Entry and Its Inhibition.
    Bortz RH; Wong AC; Grodus MG; Recht HS; Pulanco MC; Lasso G; Anthony SJ; Mittler E; Jangra RK; Chandran K
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32611759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-based design of peptide entry inhibitors targeting the endosomal receptor binding site of filoviruses.
    Wang LL; Estrada L; Wiggins J; Anantpadma M; Patten JJ; Davey RA; Xiang SH
    Antiviral Res; 2022 Oct; 206():105399. PubMed ID: 36007601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1.
    Ng M; Ndungo E; Jangra RK; Cai Y; Postnikova E; Radoshitzky SR; Dye JM; Ramírez de Arellano E; Negredo A; Palacios G; Kuhn JH; Chandran K
    Virology; 2014 Nov; 468-470():637-646. PubMed ID: 25310500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Filovirus entry: a novelty in the viral fusion world.
    Hunt CL; Lennemann NJ; Maury W
    Viruses; 2012 Feb; 4(2):258-75. PubMed ID: 22470835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Insights into the Interaction of Filovirus Glycoproteins with the Endosomal Receptor Niemann-Pick C1: A Computational Study.
    Igarashi M; Hirokawa T; Takadate Y; Takada A
    Viruses; 2021 May; 13(5):. PubMed ID: 34069246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection.
    Shoemaker CJ; Schornberg KL; Delos SE; Scully C; Pajouhesh H; Olinger GG; Johansen LM; White JM
    PLoS One; 2013; 8(2):e56265. PubMed ID: 23441171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.
    Brinkmann C; Nehlmeier I; Walendy-Gnirß K; Nehls J; González Hernández M; Hoffmann M; Qiu X; Takada A; Schindler M; Pöhlmann S
    J Virol; 2016 Dec; 90(24):11075-11086. PubMed ID: 27707924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of filovirus entry inhibitors targeting the endosomal receptor NPC1 binding site.
    Wang LL; Palermo N; Estrada L; Thompson C; Patten JJ; Anantpadma M; Davey RA; Xiang SH
    Antiviral Res; 2021 May; 189():105059. PubMed ID: 33705865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry.
    Fels JM; Spence JS; Bortz RH; Bornholdt ZA; Chandran K
    mBio; 2019 Jul; 10(4):. PubMed ID: 31289183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection.
    Isono M; Furuyama W; Kuroda M; Kondoh T; Igarashi M; Kajihara M; Yoshida R; Manzoor R; Okuya K; Miyamoto H; Feldmann H; Marzi A; Sakaitani M; Nanbo A; Takada A
    Antiviral Res; 2020 Nov; 183():104932. PubMed ID: 32946918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection
    Kummer S; Lander A; Goretzko J; Kirchoff N; Rescher U; Schloer S
    Emerg Microbes Infect; 2022 Dec; 11(1):195-207. PubMed ID: 34919035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies.
    Bornholdt ZA; Ndungo E; Fusco ML; Bale S; Flyak AI; Crowe JE; Chandran K; Saphire EO
    mBio; 2016 Feb; 7(1):e02154-15. PubMed ID: 26908579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.